Retinopathy of Prematurity: Anti-VEGF treatment for ROP: which drug and what dose?
Departments of Ophthalmology and Pediatrics, Duke University, Durham, North Carolina. Electronic address: David.Wallace@duke.edu.
David K
DK
Wallace
D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D012178:Retinopathy of Prematurity / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D042461:Vascular Endothelial Growth Factor A